- Home
- CLOV vs IMAX Comparison
CLOV vs IMAX Comparison
Compare CLOV & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLOV | IMAX |
|---|---|---|
| Founded | 2014 | 1967 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2020 | 1997 |
Fundamental Metrics
Financial Performance| Metric | CLOV | IMAX |
|---|---|---|
| Price | $4.49 | $50.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $5.38 | ★ $57.50 |
| AVG Volume (30 Days) | ★ 3.9M | 996.4K |
| Earning Date | 11-04-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.03 | 31.25 |
| EPS | 0.10 | ★ 0.35 |
| Revenue | ★ $1,924,308,000.00 | $410,212,000.00 |
| Revenue This Year | $53.58 | $13.96 |
| Revenue Next Year | $19.34 | $4.43 |
| P/E Ratio | ★ $46.85 | $147.31 |
| Revenue Growth | ★ 40.34 | 16.47 |
| 52 Week Low | $1.58 | $31.27 |
| 52 Week High | $5.59 | $57.73 |
Technical Indicators
Market Signals| Indicator | CLOV | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 42.89 |
| Support Level | $4.10 | $49.14 |
| Resistance Level | $5.19 | $55.57 |
| Average True Range (ATR) | 0.20 | 1.86 |
| MACD | 0.01 | -0.31 |
| Stochastic Oscillator | 37.73 | 32.22 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.